skip to the content

Joint Working between Roche and the NHS

At Roche we firmly believe that better patient care can be achieved through Joint Working with the NHS. This is why we support and actively implement the Department of Health guidance on Joint Working

What is Joint Working?

Joint Working is defined in the Department of Health guidance on Joint Working as:

Situations where, for the benefit of patients, one or more pharmaceutical companies and the NHS pool skills, experience and/or resources for the joint development and implementation of patient centred projects and share a commitment to successful delivery

Roche has successfully worked and continues to work alongside national, regional, and local NHS organisations to support and implement developments in healthcare delivery for the benefits of patients

Our Joint Working projects to date have aimed to:

  • Improve quality throughout a patient's healthcare pathway
  • Implement alternative models of care to increase patient access to care
  • Support redesign of disease management services
  • Better use of data to measure healthcare outcomes and reduce inequalities
  • Enable NHS spending to translate into better healthcare outcomes
  • Share good clinical practice across the NHS

All of this we believe can lead to patient benefits – access to quality healthcare services, and better healthcare outcomes.

Below is a list of Joint Working projects Roche is currently involved in. Click on the Executive Summary links below to learn more:

List of Joint Working projects Roche is currently involved in:

Project Title Start Date Organisations involved Executive Summary (PDF)
Improving patient care through the better utilisation of medicine benchmarking August 2011 NHS Life Sciences Innovation Delivery Board and Roche (45 KB)
Commissioning for Quality in Rheumatoid Arthritis (CQRA) July 2012 CQRA and Roche (47 KB)
London ICS - Patient and Career Experience Questionnaire July 2012 London Cancer and Roche Products Limited (29 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy Dataset June 2013 East and North Hertfordshire NHS Trust and Roche Products Ltd (33 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy (SACT) Dataset June 2013 East of England Strategic Clinical Network and Roche Products Ltd (33 KB)
A costed Diffuse Large B Cell Lymphoma(DLBCL) pathway October 2013 Hull & East Yorkshire NHS Trust, The University of York & Roche Products Ltd (RPL) (75 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy (SACT)Dataset October 2013
Oxford University Hospitals NHS Trust and Roche Products Ltd. (34 KB)
SACT - Summary of SACT Joint Working Projects October 2013 Roche Products Ltd and NHS (35 KB)
Commissioning for Quality in Rheumatoid Arthritis November 2013 CQRA and Roche (438 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy Dataset January 2014 The Christie NHS Foundation Trust and Roche Products Ltd. (34 KB)
SACT - Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy (SACT) Dataset March 2014 Imperial College Healthcare NHS Trust and Roche Products Ltd. (34 KB)


To see the completed Roche Joint Working Projects, click here.

For further information on existing Joint Working projects or to explore Joint Working opportunities with Roche please contact us.